Next Article in Journal
Danthron Attenuates Intestinal Inflammation by Modulating Oxidative Stress via the EGFR-PI3K-AKT and Nrf2-HO-1 Pathways
Previous Article in Journal
Heme as a Pro-Inflammatory Stimulus in Abdominal Aortic Aneurysm
Previous Article in Special Issue
miR-26a-Targeting SLC7A11 Regulates Erastin-Induced Granulosa Cell Ferroptosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ginseng Peptide Improves the Cryopreservation Efficiency and Fertilization Potential of Yak Semen via FOXO1/PI3K/AKT Axis

1
Key Laboratory for Animal Science of National Ethnic Affairs Commission, Southwest Minzu University, Chengdu 610041, China
2
Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation of Ministry of Education, Southwest Minzu University, Chengdu 610041, China
3
Sichuan Zoige Alpine Wetland Ecosystem National Observation and Research Station, Southwest Minzu University, Chengdu 610041, China
*
Authors to whom correspondence should be addressed.
Antioxidants 2026, 15(2), 156; https://doi.org/10.3390/antiox15020156
Submission received: 19 December 2025 / Revised: 15 January 2026 / Accepted: 21 January 2026 / Published: 23 January 2026

Abstract

Semen cryopreservation is a critical biotechnological approach for preserving superior genetic resources in livestock. Spermatozoa are particularly vulnerable to cryogenic stress during the freeze–thaw process, resulting in impaired structure and function. Therefore, the development of effective cryoprotective additives is essential for improving yak semen cryopreservation. In this study, ginseng peptide (GFREH) was incorporated into the freezing extender at different concentrations (0, 0.25, 0.5, 0.75, and 1.0 mg/mL) to evaluate its effects on post-thaw sperm quality, in vitro fertilization (IVF) capacity, and the underlying regulatory mechanisms. Semen samples treated with 0 and 0.75 mg/mL GFREH were further subjected to proteomic analysis to elucidate the molecular basis of its cryoprotective action. The results demonstrated that GFREH significantly increased total motility (TM), progressive motility (PM), straight-line velocity (VSL), curvilinear velocity (VCL), average path velocity (VAP), as well as plasma membrane and acrosome integrity of frozen–thawed yak spermatozoa (p < 0.05). GFREH also significantly reduced malondialdehyde (MDA) levels while enhancing antioxidant enzyme activities, mitochondrial membrane potential (MMP), and ATP content (p < 0.05). Moreover, GFREH at concentrations of 0.5, 0.75, and 1.0 mg/mL significantly improved IVF and blastocyst formation rates compared with the control (p < 0.05), with the 0.75 mg/mL group exhibiting the highest fertilization and blastocyst rates. Proteomic analysis further revealed that GFREH modulated the PI3K/AKT signaling pathway and downregulated FOXO1 expression. Collectively, these findings indicate that ginseng peptides enhance yak sperm cryotolerance by coordinating oxidative balance, mitochondrial energy metabolism, and survival-related signaling, with 0.75 mg/mL representing an optimal effective concentration within the functional dose range tested.

1. Introduction

Yaks represent an important livestock resource in the Qinghai–Tibet Plateau and surrounding regions [1]. Compared to ordinary cattle, yak possess remarkable adaptability to high-altitude environments [2]. Their unique physiological and metabolic regulatory mechanisms enable them to maintain normal growth and reproduction, under extreme high-altitude conditions such as hypoxia, cold temperatures, and intense ultraviolet radiation [3,4]. However, due to their inherently slow reproductive rate and limitations in production performance, overall yak productivity remains low [5]. Semen cryopreservation enables the global dissemination of superior genetic material through artificial insemination (AI), providing substantial benefits to the livestock industry, particularly for ruminants [6]. Artificial insemination not only effectively increases reproduction rates but also improves the genetic quality of yak populations affected by long-term inbreeding. To be effective for AI, semen must undergo both short-term and long-term cryopreservation [7]. Sperm quality after freeze–thaw cycles is also critical for normal fertilization. Accordingly, research on semen cryopreservation has long focused on improving the efficiency and success rate of sperm freezing [8].
During the freezing process, spermatozoa are highly sensitive to multiple stressors. Protein denaturation and intracellular ice crystal formation can directly impair sperm physiology, while excessive production of reactive oxygen species (ROS), cytoplasmic instability, membrane phase transitions, ion imbalance, and aberrant protease activation or inactivation may collectively induce oxidative stress [9,10]. These disruptions compromise mitochondrial integrity, plasma membrane stability, and acrosomal structure, ultimately resulting in sperm functional deterioration. To mitigate such freeze-induced damage, specific cryoprotectants must be incorporated into semen extenders to preserve sperm viability and function [11]. Numerous studies have demonstrated that enrichment of cryoprotectants with antioxidants can significantly attenuate cryo-induced oxidative stress [12]. For instance, glutathione [13], melatonin [14], and resveratrol effectively neutralize excess ROS [15], enhance antioxidant enzyme activities, and reduce lipid peroxidation products such as malondialdehyde, thereby safeguarding the structural integrity and functional competence of spermatozoa.
In recent years, increasing attention has been directed toward natural antioxidants due to the potential safety concerns associated with synthetic compounds. Among these, bioactive peptides have attracted considerable interest owing to their high biosafety, low immunogenicity, ease of synthesis, and potent antioxidant properties. The major bioactive constituents of ginseng include saponins, polysaccharides, and peptides [16]. Ginseng peptide (GFREH) is an enzymatic hydrolysate purified from ginseng roots using alkaline protease. GFREH exhibits diverse biological activities, including antioxidant effects [17], anti-inflammatory and immunomodulatory actions [18], glucose-lowering and hepatoprotective functions, as well as anti-aging and anti-fatigue effects [19]. Previous studies have shown that, in neuronal cells, ginseng peptides effectively inhibit L-Glu–induced oxidative damage, suppress Ca2+ influx, and prevent apoptosis, thereby protecting overall cellular function [20]. Moreover, they can restore nitric oxide (NO) signaling and bioavailability, attenuate oxidative stress, and protect endothelial cells from dysfunction [21].
This study investigated the effects of supplementing sperm cryoprotectant with various concentrations of ginseng peptides on the post-thaw structural integrity, motility, antioxidant capacity, and fertilization potential of yak sperm. Employing proteomics, we further elucidated the molecular mechanisms through which ginseng peptides enhance cryo-survival and identified key signaling pathways involved. The findings provide a theoretical basis for improving the cryopreservation system for yak semen.

2. Materials and Methods

2.1. Sperm Collection and Vitality Analysis

The semen samples used in this study were collected from the Longri Livestock Farm in Hongyuan County, Sichuan Province, China. Semen was collected from six sexually mature, healthy male yaks, with three ejaculates obtained from each male (total n = 18). Semen was collected individually using standard electroejaculation, and no pooling was performed. Immediately after collection, semen quality was assessed using a computer-assisted sperm analysis (CASA) system according to standardized protocols. Samples with sperm motility >90% were selected for subsequent experiments. Biological replicates corresponded to samples from different individual males, whereas repeated collections from the same male were treated as technical replicates.

2.2. Semen Freezing-Thawing Treatment

Freshly collected semen was immediately diluted (1:1, v/v) with a Tris–citric acid–fructose based transport extender containing egg yolk (R23022, Yuanye, Shanghai, China) to protect spermatozoa against cold shock, and then transported to the laboratory at 4 °C in insulated containers under dark conditions. Upon arrival, the samples were kept in the dark and allowed to equilibrate at room temperature for 30 min before further processing. GFREH powder was weighed, dissolved in distilled water, and incorporated into the thawed freezing extender to obtain final concentrations of 0.25, 0.5, 0.75, and 1.0 mg/mL. Spermatozoa equilibrated at room temperature were mixed with the freezing extender at a 1:1 ratio, after which the GFREH-supplemented extenders were added according to the respective treatment groups. The control group received the same extender without GFREH. After thorough mixing, the samples were allowed to stand at room temperature for 3 min. The semen mixtures were then loaded into 0.25 mL cryovials, sealed, and placed in prepared gauze bags. The samples were equilibrated at 4 °C for 1 h. A foam container was pre-cooled by filling it with liquid nitrogen for 5–7 min, and the cryovials were positioned 12–15 cm above the liquid nitrogen surface for 15 min to allow vapor freezing. After cool-down, the samples were submerged and stored in liquid nitrogen for one week. For thawing, the cryovials were rapidly removed from liquid nitrogen and placed in a 37 °C water bath for 1 min. The seals were then cut open to release the thawed semen into centrifuge tubes for subsequent analyses.

2.3. Sperm Motility Measurement

After thawing, semen samples were immediately analyzed using a computer-assisted sperm analysis (CASA) system (AndroVision, Minitube, Tiefenbach, Germany) with the following settings: frame rate, 60 Hz; minimum sperm size, 4 μm2; VAP threshold, 20 μm/s; VSL threshold, 30 μm/s; progressive motility was defined as VAP > 50 μm/s and STR > 70%. A microscope slide and coverslip were prepared in advance, and 2 μL of semen was pipetted onto the slide. The coverslip was gently placed over the droplet using tweezers, taking care to avoid air bubbles and without applying pressure. The sample was examined under the microscope, and 10 randomly selected fields per treatment group were analyzed to assess total motility and progressive motility. Sperm kinematics, including linear velocity (VSL), curvilinear velocity (VCL), and average path velocity (VAP), were recorded and statistically analyzed. All procedures were performed under minimal light exposure to prevent photo-induced sperm damage.

2.4. Sperm Membrane Integrity

Twenty-five microliters of thawed semen were placed into a brown centrifuge tube, and an equal volume of the Hoechst 33342/PI (Meilunbio, Dalian, Liaoning, China) mixture was added and thoroughly mixed. One microliter of the dye mixture was then added to the 25 μL semen sample and mixed gently. The samples were wrapped in aluminum foil and maintained in a 37 °C incubator in the dark for 15 min. After incubation, 10 μL of the stained semen was pipetted onto a glass slide and covered with a coverslip. Membrane integrity was assessed under a fluorescence microscope by analyzing 10 randomly selected fields per sample.

2.5. Sperm Acrosome Integrity

FITC-PNA (Sigma-Aldrich, St. Louis, MO, USA) and Hoechst 33342 were mixed at a 3:1 ratio, and 8 μL of this mixture was added to the 25 μL semen sample and mixed thoroughly. Samples were wrapped in aluminum foil and incubated in the dark at 37 °C for 20 min. After incubation, 10 μL of the stained semen was pipetted onto a glass slide and covered with a coverslip. 10 randomly selected fields per sample were analyzed under a fluorescence microscope to assess membrane and acrosome integrity.

2.6. Evaluation of ROS Level

ROS levels were measured using a commercial ROS detection kit (R6033, Uland, Nanjing, Jiangsu, China) according to the manufacturer’s protocol. Briefly, semen samples were incubated with the dye, washed to remove unbound probes, and then prepared into smears for analysis. Sections were observed under a fluorescence microscope (Olympus, Tokyo, Japan) at 630× magnification to assess overall ROS generation within sperm cells. Fluorescence intensity density was measured using a multimode microplate reader (SpectraMax iD3, Molecular Devices, San Jose, CA, USA). The relative fluorescence density for each sample was normalized based on the average fluorescence intensity of the 0 h control group.

2.7. MDA Content Detection

MDA content was measured using a commercial kit (A003-1-2, Jiancheng, Jiangsu, China). After thawing, semen samples were diluted with PBS at a ratio of 1:1 and transferred to centrifuge tubes. Reagents were added sequentially, mixed with a vortex mixer, and incubated in a 95 °C water bath for 40 min. After incubation, immediately place the samples under running water to cooled. Centrifuge at 12,000 rpm for 10 min at 4 °C. Subsequently, transfer 200 μL of supernatant to a 96-well plate. Measure absorbance at 523 nm using a microplate reader, with distilled water as the blank control.

2.8. Sperm Antioxidant Indicators

Commercial kits were used to detect the primary components of the antioxidant system in thawed yak sperm to evaluate its antioxidant capacity. The detection indicators primarily included superoxide dismutase (SOD; A001-3-2, Jiancheng, Nanjing, Jiangsu, China), catalase (CAT; A007-1-1, Jiancheng, Nanjing, Jiangsu, China), total antioxidant capacity (T-AOC; A015-3-1, Jiancheng, Nanjing, Jiangsu, China), and glutathione peroxidase (GSH-Px; S0056, Shanghai Bio-Tech, Shanghai, China). The specific operational procedures followed the manufacturers’ protocols. In brief, spermatozoa were resuspended in phosphate-buffered saline (PBS) after centrifugation. Cells were then disrupted using a homogenizer (SCIENTZIID, Ningbo, Zhejiang, China). Subsequently, samples were centrifuged at 12,000 rpm for 5 min at 4 °C, and the supernatant was collected for analysis. Each assay was performed according to the respective kit instructions. Absorbance was measured at the recommended wavelength using a spectrophotometer (Multiskan Sky, Thermo Scientific, Shanghai, China). Antioxidant levels were determined based on the standard curve provided with the kit.

2.9. Detection of Mitochondrial Membrane Potential

The commercial JC-1 mitochondrial membrane potential assay kit (J6004L, Uland, Nanjing, Jiangsu, China) was used to assess sperm MMP. Briefly, JC-1 working solution was added to each semen-containing centrifuge tube, mixed by gentle inversion several times, and incubated at 37 °C for 20 min. After incubation, samples were centrifuged at 1000 rpm for 5 min to remove the supernatant. Pellets were resuspended in pre-cooled 1× Assay Buffer, centrifuged at 1000 rpm for 5 min, and the supernatant was removed. This step was repeated once. The pellet was then resuspended in pre-cooled 1× Assay Buffer, the tube was covered, mixed using a vortex mixer, and 200 μL of supernatant was transferred to a 96-well plate for measurement using a fluorescence microplate reader. A portion of the sample was placed on a glass slide, covered with a coverslip, and observed and imaged under a fluorescence microscope.

2.10. ATP Content Assay

ATP content in sperm was measured using a commercial kit (A095-1-1, Jiancheng, Nanjing, Jiangsu, China). Place the thawed sperm sample into a centrifuge tube and centrifuge at 5000 rpm for 5 min at 4 °C. Discard the supernatant, leaving the pellet at the bottom of the tube. Resuspend the pellet in PBS, wash three times, and disrupt using an ultrasonic cell disruptor. Then centrifuge at 4 °C at 10,000 rpm for 3 min, collect the supernatant for detection.

2.11. In Vitro Fertilization Capability Assessment

Collected yak ovaries were washed three times with physiological saline containing 2% dual antibiotics. Follicular fluid was aspirated with a 10 mL syringe and transferred to cell culture dishes. Cumulus–oocyte complexes (COCs) with homogeneous cytoplasm, intact zona pellucida, and at least three layers of compact cumulus cells were selected under a stereomicroscope using egg-picking needles. Each treatment group contained 30 COCs per replicate. Selected COCs were washed two to three times and cultured in pre-equilibrated oocyte maturation medium (BO-HEPES-IVM™, HEPES-buffered oocyte maturation medium, IVF Bioscience, Falmouth, UK) at 38.5 °C in 5% CO2 for 22–24 h. Frozen yak semen was thawed in a 37 °C water bath for 30 s, transferred to capacitation medium (modified Tyrode’s medium containing 10 μg/mL heparin and 3 mg/mL BSA), and incubated at 37 °C for 1 h. During this period, mature oocytes were washed twice and placed in fresh fertilization medium (BO-IVF™, Fertilization medium, IVF Bioscience, Falmouth, UK). Fully capacitated sperm were added to the culture dishes at a final concentration of 1 × 106 sperm/mL and co-incubated with mature oocytes at 38.5 °C in 5% CO2 for 20–24 h. Presumptive zygotes were treated with 0.1% (w/v) hyaluronidase to remove cumulus cells and transferred into embryo culture medium (BO-IVC™, Embryo culture medium, IVF Bioscience, Falmouth, UK) for further development. Cleavage and blastocyst formation rates were recorded.

2.12. Labeled Quantitative Proteomics

The group without GFREH added to the sperm cryoprotectant was defined as the control group, while the group with 0.75 mg/mL GFREH added to the sperm cryoprotectant was defined as the experimental group. After thawing frozen semen from control and experimental yaks, samples were centrifuged at 800× g for 5 min in a pre-cooled high-speed refrigerated centrifuge to remove the cryodiluent. The pellet was resuspended in pre-cooled PBS, centrifuged at 800× g for 5 min, and the supernatant was removed. This procedure was repeated three times. The purified sperm was sent to Shanghai Majorbio Biomedical Technology Co, Ltd. (Shanghai, China) for proteomic experiment.

2.13. Real-Time Quantitative PCR

Total RNA was isolated using the Total RNA Isolation Kit (R1017, Zymo Research Corporation, Irvine, CA, USA) according to the manufacturer’s instructions. Reverse transcription of 1 µg of RNA was performed with the 2 × SYBR Green qRCR Mixture (Vazyme, Nanjing, Jiansu, China, R233-01). The quantitative PCR was performed using cDNA templates diluted in nuclease-free water, with amplification and detection carried out on the LightCycler®96 Real-Time PCR System (Roche Diagnostics, Basel, Switzerland). All samples were analyzed in triplicate. Using standardized β-actin as an internal reference, expression analyses of selected target genes were performed using the 2−ΔΔCT method [22].

2.14. Western Blot

After thawing yak semen samples, centrifuge to remove the supernatant. Subsequently, extract sperm proteins using the Total Protein Extraction Kit (BC3710, Solarbio, Beijing, China). Determine protein concentration with the BCA Kit (PC0020, Solarbio, Beijing, China). Total protein was separated by SDS-PAGE and transferred onto a PVDF membrane (FFP22, Beyotime, Shanghai, China), which was blocked with 5% skim milk at room temperature for 2 h. The membrane was incubated overnight at 4 °C. After three washes with TBST, the membrane was incubated with HRP-conjugated goat anti-rabbit IgG secondary antibody at room temperature for 2 h. The membrane was washed three times with TBST, visualized using an ECL kit (P0018AS, Beyotime, Shanghai, China), and images were captured using an imaging system. The primary antibody information used in the study is as follows: PI3K (1: 1000, AF6241, Affinity, Beijing, China), AKT (1: 1000, AF4691, Cell Signaling, Shanghai, China), FOXO1 (1: 3000, Huaan Biotechnology, Hongzhou, China), β-actin (1: 10,000, AF7018, Affinity, Liyang, Jiangsu, China), IgG (H + L) (1: 5000, S0001, Affinity, Liyang, Jiangsu, China). The gray values of each protein band were calculated using ImageJ software(Verson 1.48).

2.15. Data Statistical Analysis

Raw data were analyzed using SPSS 26 (SPSS Inc., Chicago, IL, USA), and two-way analysis of variance (ANOVA) was performed using GraphPad Prism (version: 8.01) to compare mean values among treatment groups. Each experiment was conducted in triplicate, and the mean value of the replicates was calculated. Results are presented as mean ± standard error of the mean (SEM). Differences were considered statistically significant at p < 0.05.

3. Results

3.1. Effects of GFREH on Sperm Vitality

The effect of GFREH on the motility of frozen-thawed yak sperm is shown in Figure 1. The result of frozen–thawed sperm (Figure 1A) revealed that compared with the control group, total motility was significantly increased in sperm treated with 0.25, 0.5, 0.75, and 1 mg/mL GFREH (Figure 1B, p < 0.05). Among these, sperm treated with 0.75 mg/mL GFREH exhibited the highest total motility (p < 0.05), whereas the 1 mg/mL group showed lower motility than the 0.75 mg/mL group (p < 0.05). The forward motility (Figure 1C) showed that sperm treated with 0.5, 0.75, and 1 mg/mL GFREH had significantly higher forward motility compared with the control group (p < 0.05). Among these, the 0.75 mg/mL group exhibited the highest forward motility (p < 0.05). Compared with the control, sperm treated with 0.25, 0.5, 0.75, and 1 mg/mL GFREH exhibited significantly higher VSL, VCL and VAP (Figure 1D–F), with the 0.75 mg/mL group showing the highest VSL, VCL and VAP, whereas the 1 mg/mL group displayed lower VSL than the 0.75 mg/mL group (p < 0.05).

3.2. Effects of GFREH Supplementation on Membrane and Acrosome Integrity of Frozen Sperm

The fluorescence-based assessment of plasma membrane integrity in frozen–thawed yak sperm treated with different concentrations of GFREH is shown in Figure 2A. The plasma membrane integrity revealed that, compared with the control, sperm treated with 0.25, 0.5, 0.75, and 1 mg/mL GFREH exhibited reduced membrane damage. Among these, the 0.75 mg/mL group showed the largest reduction in membrane damage (p < 0.05), whereas no significant difference was observed between the 0.25 and 1 mg/mL groups (Figure 2B, p > 0.05). The fluorescence-based assessment of acrosome integrity in yak sperm treated with different concentrations of GFREH is shown in Figure 2C. Following Hoechst 33342 staining, the sperm nucleus emits blue fluorescence. Concurrently, if the acrosome is intact, FITC-PNA staining produces crescent-shaped green fluorescence that overlays the blue nuclear signal. Conversely, if only blue fluorescence is observed without overlapping green fluorescence, the acrosome is considered damaged. The acrosome integrity analysis showed that sperm treated with 0.5, 0.75, and 1 mg/mL GFREH exhibited significantly reduced acrosome damage compared to the control (p < 0.05). Although the 0.75 mg/mL group had the numerically lowest damage rate, the differences among the three GFREH treated groups were not statistically significant (Figure 2D).

3.3. The Effect of GFREH on Sperm Antioxidant Indicators

ROS levels in sperm treated with ROS detection reagents are shown in Figure 3A. Green fluorescence intensity indicates ROS content, with higher fluorescence corresponding to increased ROS levels. Compared to the control group, adding 0.5, 0.75, and 1 mg/mL GFREH to the semen dilution medium significantly reduced ROS levels in freeze-thawed yak sperm (p < 0.05). Among these treatment groups, the 0.75 mg/mL GFREH group exhibited the lowest ROS content (Figure 3B). Similarly, malondialdehyde (MDA) levels were significantly decreased in all GFREH treated groups compared with the control (Figure 3C, p < 0.05), with the 0.75 mg/mL group showing the lowest MDA content. Treatment with 0.5, 0.75, and 1 mg/mL GFREH significantly increased superoxide dismutase (SOD) and CAT levels (Figure 3E,F, p < 0.05), with the 0.75 mg/mL group exhibiting the highest SOD content. Moreover, total antioxidant capacity (T-AOC) and GSH-Px was significantly increased in all treatment groups (Figure 3D,G, p < 0.05), with the 0.75 mg/mL group exhibiting the strongest antioxidant capacity.

3.4. Effects of GFREH on Sperm Mitochondrial Function

Mitochondrial membrane potential (MMP) in yak sperm was assessed (Figure 4A). Addition of GFREH to the sperm diluent significantly increased MMP (p < 0.05), with the 0.75 mg/mL group exhibiting the highest MMP. In contrast, the 1 mg/mL GFREH group showed a lower MMP than the 0.75 mg/mL group (p < 0.05). ATP levels in yak sperm were measured (Figure 4B). Compared with the control, the 0.25 mg/mL GFREH group showed no significant change in ATP content (p > 0.05), whereas the 0.5, 0.75, and 1 mg/mL GFREH groups exhibited significant increases (p < 0.05), with the 0.75 mg/mL group showing the highest ATP level (p < 0.05).

3.5. Effects of GFREH Treatment on the Fertilization Potential of Frozen Sperm

The yak sperm fertilization rates at different GFREH concentrations revealed that treatment with 0.5 mg/mL, 0.75 mg/mL, and 1 mg/mL GFREH significantly increased fertilization rates (p < 0.05), with the 0.75 mg/mL group showing the highest fertilization rate (Figure 5A, p < 0.05). Blastocyst rate analysis indicated that addition of 0.5 mg/mL, 0.75 mg/mL, and 1 mg/mL GFREH significantly increased the blastocyst rate compared with the control (p < 0.05). The 0.75 mg/mL group exhibited the highest blastocyst rate (p < 0.05), whereas the 1 mg/mL group showed a decrease compared with the control (Figure 5B, p < 0.05).

3.6. Identification and Analysis of Proteomics

Using a significance threshold of p ≤ 0.05 and FC ≥ 1.2 or ≤0.83, 85 differentially expressed proteins (DEPs) were identified, comprising 42 upregulated proteins and 43 downregulated proteins. Among these, FOXO1 exhibited the highest fold change among downregulated proteins in the experimental group compared to the control group (Figure 6A). KEGG enrichment analysis indicates that DEPs are primarily enriched in ECM-receptor interactions, ribosomes, focal adhesions, and the PI3K-AKT signaling pathway. The downregulated differential protein FOXO1 is also enriched in the PI3K-AKT signaling pathway (Figure 6B,D). Gene ontology (GO) analysis revealed that DEPs were primarily enriched in biological processes such as cellular processes, metabolism, biological regulation, localization, development, homeostasis, and immune system functions. In terms of cellular components, enrichment was observed in cell structures, organelles, and protein complexes. Regarding molecular functions, DEPs were mainly associated with binding, catalytic activity, transporter activity, molecular function regulation, and ATP-dependent activity (Figure 6C).

3.7. GFREH Reduces FOXO1 Expression Levels Through the PI3K/AKT Signaling Axis

Analysis of mRNA expression levels of PIK3R1, AKT1, and FOXO1 in the control and 0.75 mg/mL GFREH treatment groups revealed that 0.75 mg/mL GFREH significantly increased PIK3R1 and AKT1 expression (p < 0.05) while decreasing FOXO1 expression (p < 0.05). The mRNA levels in yak sperm treated with an AKT activator demonstrated that the 0.75 mg/mL GFREH group, 0 + AKT activator group, and 0.75 + AKT activator group all significantly upregulated PIK3R1 and AKT1 expression (p < 0.05) and downregulated FOXO1 expression (p < 0.05). In the 0 + PI3K inhibitor group, mRNA levels did not differ significantly from the control (p > 0.05). However, in the 0.75 + PI3K inhibitor group, PIK3R1 and AKT1 expression was significantly reduced while FOXO1 expression was increased compared with the 0.75 mg/mL GFREH group (Figure 7A–C, p < 0.05). Treatment with 0.75 mg/mL GFREH significantly increased PI3K and AKT protein expression (p < 0.05) and decreased FOXO1 expression (p < 0.05). Analysis of protein expression in sperm treated with an AKT activator showed that the 0.75 mg/mL GFREH group, 0 + AKT activator group, and 0.75 + AKT activator group all significantly upregulated PI3K and AKT expression (p < 0.05) and downregulated FOXO1 expression (p < 0.05). Protein expression analysis following PI3K inhibitor treatment indicated that the 0.75 mg/mL GFREH group significantly increased PI3K and AKT expression (p < 0.05) and decreased FOXO1 expression (p < 0.05). In the 0 + PI3K inhibitor group, protein levels did not differ significantly from the control (p > 0.05). However, in the 0.75 + PI3K inhibitor group, PI3K and AKT expression was significantly reduced, while FOXO1 expression was increased compared with the 0.75 mg/mL GFREH group (Figure 7D–F, p < 0.05).

4. Discussion

Semen freezing represents a major advancement in artificial insemination technology, facilitating the utilization of high-quality male livestock and accelerating the improvement of livestock breeds [23]. Simultaneously, it provides convenient channels for livestock introduction, promoting the exchange of high-quality semen across regions [24].
Sperm vitality and motility are key indicators of sperm quality and are widely used in evaluating sperm function [25,26,27]. Studies have demonstrated that at a concentration of 50 nM, progesterone significantly enhances the vitality of vitrified sperm and optimizes motility-related parameters of frozen sperm [28]. Adding 100 μM cysteine to buffalo semen enhances post-thaw sperm motility, antioxidant capacity, and DNA integrity [29]. Furthermore, during sperm capacitation, the plasma membrane participates in the acrosome reaction and plays a crucial role [30]. Intracellular calcium fine balance in the sperm cytoplasm is strictly dependent on sperm surface channels including the CatSper channel. Disruption or mutation of CatSper leads to impaired male fertility [31,32]. Supplementation with bovine serum albumin (BSA) in thawing diluents effectively enhances sperm plasma membrane integrity and acrosome status after thawing [33]. Adding melatonin (MLT) improves sperm cryopreservation outcomes by regulating receptors (MT1/MT2) on the sperm membrane, thereby influencing sperm capacitation, the acrosome reaction, lipid peroxidation, and DNA integrity [34]. Our results demonstrate that GFREH exerts a clear dose-dependent effect on yak sperm quality. While GFREH improved sperm quality and related parameters at 0.5 and 0.75 mg/mL, the effect was slightly reduced at 1 mg/mL. This may reflect a saturation effect or potential mild cytotoxicity at higher concentrations. Notably, the 0.75 mg/mL concentration produced the most stable and robust improvements, particularly in forward motility, linear velocity, and plasma membrane integrity. This pattern suggests that GFREH acts within an optimal concentration window, beyond which its beneficial effects may be attenuated due to saturation of cellular targets or the onset of mild cytotoxic or oxidative stress at higher doses.
ROS refers to the collective term for substances composed of oxygen and reactive oxygen species within the body or natural environment [35]. Elevated levels of ROS can adversely affect sperm motility, including damage to the sperm plasma membrane, mitochondria, DNA, and epigenetics [36]. Studies have shown that polysaccharides, used as protective agents, effectively reduce reactive oxygen species (ROS) levels during the freeze–thaw process [37]. In studies on rooster semen cryopreservation, supplementation with alpha-linolenic acid (ALA) significantly increased the activity of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), while simultaneously reducing malondialdehyde (MDA) levels [38]. Moreover, ALA improved mitochondrial membrane potential (MMP) and decreased both early and late-stage sperm apoptosis [39]. In addition to small-molecule antioxidants, ginseng and its bioactive components have demonstrated significant protective effects on male reproductive function across multiple animal models. In avian models, supplementation of freezing media with Panax ginseng extract improved post-thaw sperm motility, membrane integrity, and antioxidant enzyme activity while reducing lipid peroxidation [40]. In ruminants, aqueous Panax ginseng extract enhanced the quality of chilled and cryopreserved bull sperm in a dose-dependent manner, maintaining motility, viability, and chromatin integrity, while pure ginseng improved testicular function in rams, as reflected in hormonal and histological parameters [41,42]. Although studies on ginseng peptides in yak or other ruminant semen are limited, these findings collectively support the antioxidant and cytoprotective potential of ginseng-derived compounds for improving sperm quality across taxa. The results of this study are consistent with these findings. Compared with the control group, GFREH supplementation significantly increased the levels of antioxidant enzymes, including SOD and T-AOC, in yak sperm, enhanced total antioxidant capacity, and reduced MDA content. These results indicate that GFREH supplementation enhances the antioxidant capacity of frozen yak sperm and mitigates freeze-induced oxidative stress. During cryopreservation, sperm mitochondria are highly susceptible to damage. Based on these findings, it is suggested that enhanced cryoprotectants may help preserve the structural integrity and functional stability of vulnerable sperm mitochondria during cryopreservation, thereby preventing the initiation of apoptosis [43]. These results suggest that GFREH exerts similar antioxidant effects and may function as an antioxidant in yak semen cryoprotectant diluents.
In the freeze-thawed cycle, freezing damage will lead to mRNA degradation, affecting the function and expression of fertility-related proteins [44]. To optimize and improve semen cryopreservation techniques, researchers have employed differential proteomics to investigate the mechanisms of freezing-induced injury across different species [45,46]. Bovine sperm proteomics reveal that antioxidant enzymes maintain sperm viability by regulating ROS generated during cryopreservation, thereby preventing oxidative stress and apoptosis in sperm [47]. Supplementing sperm cryoprotectants with 10 μM mitoquinone (MitoQ) enhances antioxidant capacity and glucose transporter abundance in boar sperm [48]. In this study, it was found that adding 0.75 mg/mL GFREH to sperm cryoprotectants resulted in DEPs primarily participating in biological processes such as transporter activity and ATP-dependent activity. Among these, FOXO1 protein exhibited the highest fold change among downregulated proteins in the experimental group compared to the control group. This indicates that FOXO1 plays a crucial regulatory role during sperm cryopreservation.
The forkhead box O1 (FOXO1) gene functions in multiple aspects including cell proliferation, apoptosis, inflammatory response, immune differentiation, and antioxidant stress [49]. In polycystic ovary syndrome (PCOS), FOXO1 is considered a key regulator of chronic inflammation, and knocking down FOXO1 can alleviate inflammatory and immune responses in a rat model of PCOS [49,50]. Studies have shown that non-esterified fatty acids (NEFA) significantly inhibit phosphatidylinositol 3-kinase (PI3K) and phosphorylated protein kinase B (p-AKT) activity, while increasing the expression of FOXO1 [51]. The mechanism of FOXO1 inhibition through the PI3K-AKT signaling pathway aligns with reports from other cellular systems AKT-mediated phosphorylation can lead to cytoplasmic retention of FOXO transcription factors, consequently suppressing the transcription of pro-apoptotic and oxidative stress-related genes [52,53]. This suggests that PI3K-AKT-FOXO1 regulation may be a conserved mechanism protecting sperm from cryopreservation-induced oxidative damage. In this study, activation of the PI3K-AKT signaling pathway inhibited the expression of the key protein FOXO1, thereby reducing oxidative stress in yak sperm, enhancing antioxidant defenses, and improving sperm quality. These results provide a theoretical foundation for use of GFREH as a cryoprotectant for yak semen.

5. Conclusions

This study demonstrates that ginseng peptides serve as an effective natural cryoprotectant for yak semen, improving post-thaw sperm quality by synergistically regulating oxidative balance, mitochondrial function, and survival-related signaling pathways. Within the tested concentration range (0.5–1.0 mg/mL), GFREH exhibited a pronounced dose-dependent protective pattern, with the 0.75 mg/mL concentration achieving an optimal balance between efficacy and cellular tolerance. Proteomics evidence further suggests that activation of the PI3K/AKT-FOXO1 axis may underlie its cytoprotective action, revealing the molecular mechanism by which GFREH promotes sperm survival under cryostress conditions. Collectively, these findings highlight the potential of ginseng peptides as bioactive additives for improving yak semen cryopreservation and support further evaluation of their optimal dosage and application in livestock reproductive biotechnology.

Author Contributions

Conceptualization, J.Y. and X.L.; methodology, X.L.; software, Y.L. and Z.C.; validation, R.Z., Y.W. and C.Z.; formal analysis, D.Z.; investigation, X.L.; resources, Y.C.; data curation, J.Y.; writing—original draft preparation, X.L.; writing—review and editing, X.X.; visualization, Y.X.; visualization, S.Y.; project administration, X.X.; funding acquisition, supervision, J.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Key Research and Development Program, grant number 2023YFD1300603, the Special Project of Sichuan Beef Cattle Innovation Team of the National Agricultural Industrial Technology System grant number SCCXTD-2024-13, the Project of Qinghai-Tibetan Plateau Research grant number 2024CXTD05, and the Fundamental Research Funds for the Central Universities of Southwest Minzu University grant number ZYN2024177.

Institutional Review Board Statement

All experimental procedures were conducted in compliance with the guidelines approved by the Animal Care and Ethics Committee of Southwest Minzu University (Approval number: SMU-CAVS-240211036, granted on 10 October 2024).

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the cor-responding authors.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ayalew, W.; Chu, M.; Liang, C.; Wu, X.; Yan, P. Adaptation mechanisms of yak (Bos grunniens) to high-altitude environmental stress. Animals 2021, 11, 2344. [Google Scholar] [CrossRef]
  2. Ding, X.; Liang, C.; Guo, X.; Wu, X.; Wang, H.B.; Johnson, K.A.; Yan, P. Physiological insight into the high-altitude adaptations in domesticated yaks (Bos grunniens) along the Qinghai-Tibetan Plateau altitudinal gradient. Livest. Sci. 2014, 162, 233–239. [Google Scholar] [CrossRef]
  3. Liu, X.; Gao, J.; Liu, S.; Cheng, Y.; Hao, L.; Liu, S.; Zhu, W. The uniqueness and superiority of energy utilization in yaks compared with cattle in the highlands: A review. Anim. Nutr. 2022, 12, 138–144. [Google Scholar] [CrossRef] [PubMed]
  4. Jing, X.; Ding, L.; Zhou, J.; Huang, X.; Degen, A.A.; Long, R. The adaptive strategies of yaks to live in the Asian highlands. Anim. Nutr. 2022, 9, 249–258. [Google Scholar] [CrossRef] [PubMed]
  5. Li, Y.; Wang, J.; Ma, J.; Hu, S.; Yang, Y.; Yang, C.; Huo, S.; Yang, Y.; Zhaxi, Y. Differentially expressed transcripts study during pregnancy and postpartum anestrus of yak (Bos grunniens). Anim. Biotechnol. 2023, 34, 4041–4049. [Google Scholar] [CrossRef]
  6. Lv, C.; Wu, G.; Hong, Q.; Quan, G. Spermatozoa cryopreservation: State of art and future in small ruminants. Biopreserv. Biobank. 2019, 17, 171–182. [Google Scholar] [CrossRef]
  7. Kalwar, Q.; Chu, M.; Korejo, R.A.; Soomro, H.; Yan, P. Cryopreservation of yak semen: A comprehensive review. Animals 2022, 12, 3451. [Google Scholar] [CrossRef]
  8. Ezzati, M.; Shanehbandi, D.; Hamdi, K.; Rahbar, S.; Pashaiasl, M. Influence of cryopreservation on structure and function of mammalian spermatozoa: An overview. Cell Tissue Bank. 2020, 21, 1–15. [Google Scholar] [CrossRef]
  9. Ugur, M.R.; Abdelrahman, A.S.; Evans, H.; Gilmore, A.; Hitit, M.; Arifiantini, R.I.; Purwantara, B.; Kaya, A.; Memili, E. Advances in cryopreservation of bull sperm. Front. Vet. Sci. 2019, 6, 268. [Google Scholar] [CrossRef]
  10. Mohammadi, A.; Jafarpour, F.; Vash, N.T.; Hajian, M.; Nasr-Esfahani, M.H. Supplementation of sperm cryopreservation media with H2S donors enhances sperm quality, reduces oxidative stress, and improves in vitro fertilization outcomes. Sci. Rep. 2024, 14, 12400. [Google Scholar] [CrossRef]
  11. Hezavehei, M.; Sharafi, M.; Kouchesfahani, H.M.; Henkel, R.; Agarwal, A.; Esmaeili, V.; Shahverdi, A. Sperm cryopreservation: A review on current molecular cryobiology and advanced approaches. Reprod. Biomed. Online 2018, 37, 327–339. [Google Scholar] [CrossRef] [PubMed]
  12. Kumar, P.; Kumar, R.; Mehta, J.; Chaudhary, A.; Ravi, S.K.; Mehta, S.C.; Ansari, M.M.; Legha, R.A.; Tripathi, B.N.; Talluri, T.R. Ameliorative effect of ascorbic acid and glutathione in combating the cryoinjuries during cryopreservation of exotic jack semen. J. Equine Vet. Sci. 2019, 81, 102796. [Google Scholar] [CrossRef] [PubMed]
  13. Ogata, K.; Imai, A.; Sato, S.; Nishino, K.; Watanabe, S.; Somfai, T.; Kobayashi, E.; Takeda, K. Effects of reduced glutathione supplementation in semen freezing extender on frozen-thawed bull semen and in vitro fertilization. J. Reprod. Dev. 2022, 68, 53–61. [Google Scholar] [CrossRef] [PubMed]
  14. Deng, S.; Sun, T.C.; Yu, K.; Wang, Z.; Zhang, B.L.; Zhang, Y.; Wang, X.; Lian, Z.; Liu, Y. Melatonin reduces oxidative damage and upregulates heat shock protein 90 expression in cryopreserved human semen. Free Radic. Biol. Med. 2017, 113, 347–354. [Google Scholar] [CrossRef]
  15. Garcez, M.; Branco, C.S.; Lara, L.V.; Pasqualotto, F.F.; Salvador, M. Effects of resveratrol supplementation on cryopreservation medium of human semen. Fertil. Steril. 2010, 94, 2118–2121. [Google Scholar] [CrossRef]
  16. Su, J.; Su, Q.; Hu, S.; Ruan, X.; Ouyang, S. Research progress on the Anti-Aging potential of the active components of ginseng. Nutrients 2023, 15, 3286. [Google Scholar] [CrossRef]
  17. He, L.; Wang, J.; Sun, B.; Zhao, J.; Li, L.; Xu, T.; Li, H.; Jing-Qin, S.; Ren, J.; Liu, R.; et al. Suppression of TNF-α and free radicals reduces systematic inflammatory and metabolic disorders: Radioprotective effects of ginseng oligopeptides on intestinal barrier function and antioxidant defense. J. Nutr. Biochem. 2017, 40, 53–61. [Google Scholar] [CrossRef]
  18. He, L.; Ren, J.; Liu, R.; Chen, Q.; Zhao, J.; Wu, X.; Zhang, Z.; Wang, J.; Pettinato, G.; Li, Y. Ginseng (Panax ginseng Meyer) oligopeptides regulate innate and adaptive immune responses in mice via increased macrophage phagocytosis capacity, NK cell activity and Th cells secretion. Food Funct. 2017, 8, 3523–3532. [Google Scholar] [CrossRef]
  19. Zhu, N.; Xu, M.; Li, Y. Bioactive oligopeptides from ginseng (Panax ginseng Meyer) suppress oxidative stress-induced senescence in fibroblasts via NAD+/SIRT1/PGC-1α signaling pathway. Nutrients 2022, 14, 5289. [Google Scholar] [CrossRef]
  20. Yan, X.; Chen, X.; Fu, C.; Jing, C.; Zhao, D.; Sun, L. Ginseng oligosaccharides protect neurons from glutamate-induced oxidative damage through the Nrf2/HO-1 signaling pathway. Food Funct. 2022, 13, 8605–8615. [Google Scholar] [CrossRef]
  21. Dutta, B.; Loo, S.; Kam, A.; Sze, S.K.; Tam, J.P. Ginsentide TP1 protects hypoxia-induced dysfunction and ER stress-linked apoptosis. Cells 2023, 12, 1401. [Google Scholar] [CrossRef]
  22. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  23. Rakha, B.A.; Ansari, M.S.; Akhter, S.; Zafar, Z.; Naseer, A.; Hussain, I.; Moreno, J.S.; Blesbois, É. Dimethyleacetamide improves the cryosurvivability of Indian red jungle fowl (Gallus gallus murghi) sperm. Theriogenology 2017, 103, 83–89. [Google Scholar] [CrossRef] [PubMed][Green Version]
  24. Gangwar, C.; Kharche, S.D.; Mishra, A.K.; Saraswat, S.; Kumar, N.; Sikarwar, A.K.S. Effect of diluent sugars on capacitation status and acrosome reaction of spermatozoa in buck semen at refrigerated temperature. Trop. Anim. Health Prod. 2020, 52, 3409–3415. [Google Scholar] [CrossRef] [PubMed]
  25. Gündoğan, M.; Yeni, D.; Avdatek, F.; Fidan, A.F. Influence of sperm concentration on the motility, morphology, membrane and DNA integrity along with oxidative stress parameters of ram sperm during liquid storage. Anim. Reprod. Sci. 2010, 122, 200–207. [Google Scholar] [CrossRef] [PubMed]
  26. Sohail, A.; Andrabi, S.M.H.; Anwar, M.; Ali, L.C.; Mehmood, A. Assessment of buffalo bull semen quality based on sperm motility parameters, motion characteristics and in vitro fertilization rate. Pak. Vet. J. 2013, 33, 53–56. [Google Scholar]
  27. Yeste, M.; Estrada, E.; Pinart, E.; Bonet, S.; Miró, J.; Gil, J.E.R. The improving effect of reduced glutathione on boar sperm cryotolerance is related with the intrinsic ejaculate freezability. Cryobiology 2014, 68, 251–261. [Google Scholar] [CrossRef]
  28. Saymé, N.; Dite, L.; Krebs, T.; Kljajić, M.; Maas, D.H.A. Positive effect of progesterone on motility and velocity of fresh, vitrified without permeable cryoprotectants and frozen with permeable cryoprotectants human spermatozoa. Andrologia 2018, 50, e13133. [Google Scholar] [CrossRef]
  29. Elkhawagah, A.R.; Martino, N.A.; Kandiel, M.M.M.; Mahmoud, K.G.; Ricci, A.; Vincenti, L. Effects of cysteamine supplementation on cryopreserved buffalo bull semen quality parameters. Theriogenology 2022, 192, 141–149. [Google Scholar] [CrossRef]
  30. Sutkevičienė, N.; Riškevičienė, V.; Januškauskas, A.; Zilinskas, H.; Andersson, M. Assessment of sperm quality traits in relation to fertility in boar semen. Acta Vet. Scand. 2009, 51, 53. [Google Scholar] [CrossRef]
  31. Moskovtsev, S.I.; Willis, J.; Azad, A.; Mullen, J.B. Sperm DNA integrity: Correlation with sperm plasma membrane integrity in semen evaluated for male infertility. Arch. Androl. 2005, 51, 33–40. [Google Scholar] [CrossRef]
  32. Antonouli, S.; Nisio, V.D.; Messini, C.; Samara, M.; Salumets, A.; Daponte, A.; Anifandis, G. Sperm plasma membrane ion transporters and male fertility potential: A perspective under the prism of cryopreservation. Cryobiology 2024, 114, 104845. [Google Scholar] [CrossRef] [PubMed]
  33. Rodríguez, M.Á.; Cristóbal, H.N.; de Mercado, E. Bovine serum albumin inclusion in the thawing extender improves boar sperm membrane and acrosomal integrity. Reprod. Domest. Anim. 2024, 59, e14592. [Google Scholar] [CrossRef] [PubMed]
  34. Padilla, A.J.C.; Trejo, F.J.; Cerbon, M.; Garcia, A.C.; Cano, N.B.C.; Torres, M.M.; Rodriguez, A.A.; Medrano, A. Sperm melatonin receptors, seminal plasma melatonin and semen freezability in goats. Theriogenology 2024, 225, 98–106. [Google Scholar] [CrossRef] [PubMed]
  35. Kozlov, A.V.; Javadov, S.; Sommer, N. Cellular ROS and antioxidants: Physiological and pathological role. Antioxidants 2024, 13, 602. [Google Scholar] [CrossRef]
  36. Xu, Z.; Yan, Q.; Zhang, K.; Lei, Y.; Zhou, C.; Ren, T.; Gao, N.; Wen, F.; Li, X. Mitochondrial regulation of spermatozoa function: Metabolism, oxidative stress and therapeutic insights. Animals 2025, 15, 2246. [Google Scholar] [CrossRef]
  37. Sariözkan, S.; Bucak, M.N.; Tuncer, P.B.; Ulutaş, P.A.; Bilgen, A. The influence of cysteine and taurine on microscopic-oxidative stress parameters and fertilizing ability of bull semen following cryopreservation. Cryobiology 2009, 58, 134–138. [Google Scholar] [CrossRef]
  38. Long, C.; Yin, X.; Sheng, X.; Wang, X.; Xiao, L.; Qi, X. Dietary alpha-linolenic acid supplementation enhances semen quality, antioxidant capacity, and sperm survival in aging breeder roosters. Poult. Sci. 2024, 103, 104252. [Google Scholar] [CrossRef]
  39. Chen, X.; Liu, J.; Liu, Y.; Li, X.; An, D.; Liu, X.; Zhang, L. Alpha-lipoic acid improves cryopreservation of rooster semen by reducing oxidative stress. Poult. Sci. 2024, 103, 103632. [Google Scholar] [CrossRef]
  40. Ratchamak, R.; Authaida, S.; Koedkanmark, T.; Boonkum, W.; Semaming, Y.; Chankitisakul, V. Supplementation of freezing medium with ginseng improves rooster sperm quality and fertility relative to free radicals and antioxidant enzymes. Animals 2023, 13, 2660. [Google Scholar] [CrossRef]
  41. Baiee, F.; Haron, A.W.; AL-mudhafr, M.A.; Peter, I.D.; Yimer, N. Can Panax Ginseng Aqueous Extract Improve Chilled and Cryopreserved Bull Spermatozoa? Agric. Sci. 2020, 2, 15. [Google Scholar] [CrossRef]
  42. Sanad, N.H.; Abbas, H.R.; Yaseen, A.A.; Habeeb, I.A.; Alsalim, H.A. Hormonal, histological, and comparative study of the effect of pure ginseng on testicular function in the breeding/non-breeding season of rams in basrah. Arch. Razi Inst. 2021, 76, 1519–1535. [Google Scholar] [CrossRef] [PubMed]
  43. Yan, B.; Zhang, X.; Wang, J.; Jia, S.; Zhou, Y.; Tian, J.; Wang, H.; Tang, Y. Inhibitory effect of Lycium barbarum polysaccharide on sperm damage during cryopreservation. Exp. Ther. Med. 2020, 20, 3051–3063. [Google Scholar] [CrossRef] [PubMed]
  44. Card, C.; Anderson, E.J.; Zamberlan, S.; Krieger, K.E.; Kaproth, M.; Sartini, B.L. Cryopreserved bovine spermatozoal transcript profile as revealed by high-throughput ribonucleic acid sequencing. Biol. Reprod. 2013, 88, 49. [Google Scholar] [CrossRef] [PubMed]
  45. Fan, Y.; Li, X.; Guo, Y.; He, X.; Wang, Y.; Zhao, D.; Ma, Y.; Feng, X.; Zhang, J.; Li, J.; et al. TMT-based quantitative proteomics analysis reveals the differential proteins between fresh and frozen-thawed sperm of yak (Bos grunniens). Theriogenology 2023, 200, 60–69. [Google Scholar] [CrossRef]
  46. Wang, N.; Yang, M.; He, D.; Li, X.; Zhang, X.; Han, B.; Liu, C.; Hai, C.; Li, G.; Zhao, Y. TMT-based quantitative N-glycoproteomic analysis reveals glycoprotein protection can improve the quality of frozen bovine sperm. Int. J. Biol. Macromol. 2022, 218, 168–180. [Google Scholar] [CrossRef]
  47. Zhang, R.; Wang, X.; Liu, R.; Mei, Y.; Miao, X.; Ma, J.; Zou, L.; Zhao, Q.; Bai, X.; Dong, Y. Proteomics and metabolomics analyses of mechanism underlying bovine sperm cryoinjury. BMC Genom. 2025, 26, 63. [Google Scholar] [CrossRef]
  48. Shi, L.; Zhang, Y.; Huang, X.; Shi, M.; Sun, D.; Zhang, Y.; Li, W.; Jin, T.; Feng, J.; Xing, J.; et al. Effects of mitoquinone (MitoQ) supplementation during boar semen cryopreservation on sperm quality, antioxidant status and mitochondrial proteomics. Anim. Reprod. Sci. 2022, 247, 107099. [Google Scholar] [CrossRef]
  49. Xu, R.; Wang, Z. Involvement of transcription factor Foxo1 in the pathogenesis of polycystic ovary syndrome. Front. Physiol. 2021, 12, 649295. [Google Scholar] [CrossRef]
  50. Huang, X.; Luo, X.; Huang, S.; Chen, X.; Qiu, L. Inhibition of Foxo1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response. Funct. Integr. Genom. 2024, 24, 6. [Google Scholar] [CrossRef]
  51. Lei, Z.; Ali, I.; Yang, M.; Yang, C.X.; Li, Y.; Li, L. Non-Esterified fatty Acid-Induced apoptosis in bovine granulosa cells via ROS-Activated PI3K/AKT/Foxo1 pathway. Antioxidants 2023, 12, 434. [Google Scholar] [CrossRef]
  52. Kim, D.H.; Park, C.H.; Park, D.; Choi, Y.J.; Park, M.H.; Chung, K.W.; Kim, S.R.; Lee, J.S.; Chung, H.Y. Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress. Arch. Pharm. Res. 2013, 37, 813–820. [Google Scholar] [CrossRef]
  53. Yan, C.; Ou, Y.; Sun, X.; Sun, Y.; Zhao, J.; Qin, N.; Xu, R. FSH-Induced nuclear exclusion of FOXO1 mediated by PI3K/Akt signaling pathway in granulosa cells is associated with follicle selection and growth of the hen ovary. Cells 2025, 14, 1864. [Google Scholar] [CrossRef]
Figure 1. The effect of different concentrations of GFREH on the sperm motility of frozen thawed yaks. (A) Sperm motility test. Schematic diagram of sperm movement trajectory. Green represents forward moving sperm, yellow represents stationary moving sperm, and red represents stationary sperm. (B) Total sperm motility (%). (C) Progressive sperm motility (%). (D) Sperm linear velocity (μ m/s). (E) Sperm curve velocity (μ m/s). (F) The average path velocity of sperm (μ m/s). Different letters represent the significant difference. Data in (B,C) are presented as mean ± SEM. Data in (DF) are shown as violin plots representing the distribution of individual ejaculates (n = 18), with the central line indicating the median and dashed lines representing the interquartile range. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 1. The effect of different concentrations of GFREH on the sperm motility of frozen thawed yaks. (A) Sperm motility test. Schematic diagram of sperm movement trajectory. Green represents forward moving sperm, yellow represents stationary moving sperm, and red represents stationary sperm. (B) Total sperm motility (%). (C) Progressive sperm motility (%). (D) Sperm linear velocity (μ m/s). (E) Sperm curve velocity (μ m/s). (F) The average path velocity of sperm (μ m/s). Different letters represent the significant difference. Data in (B,C) are presented as mean ± SEM. Data in (DF) are shown as violin plots representing the distribution of individual ejaculates (n = 18), with the central line indicating the median and dashed lines representing the interquartile range. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g001
Figure 2. The impact of freezing on the integrity of sperm plasma membrane. (A) Fluorescence spectra of intact plasma membrane of frozen thawed yak sperm treated with different concentrations of GFREH. Spermatozoa with intact membranes appeared as blue fluorescence dots, while those with damaged membranes appeared as pink or red dots. (B) The effect of different concentrations of GFREH on the plasma membrane integrity of frozen thawed yak sperm. (C) Fluorescence spectra of intact acrosome of frozen thawed yak sperm treated with different concentrations of GFREH. (D) The effect of different concentrations of GFREH on the integrity of the acrosome of yak sperm after freezing thawing. Data are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 2. The impact of freezing on the integrity of sperm plasma membrane. (A) Fluorescence spectra of intact plasma membrane of frozen thawed yak sperm treated with different concentrations of GFREH. Spermatozoa with intact membranes appeared as blue fluorescence dots, while those with damaged membranes appeared as pink or red dots. (B) The effect of different concentrations of GFREH on the plasma membrane integrity of frozen thawed yak sperm. (C) Fluorescence spectra of intact acrosome of frozen thawed yak sperm treated with different concentrations of GFREH. (D) The effect of different concentrations of GFREH on the integrity of the acrosome of yak sperm after freezing thawing. Data are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g002
Figure 3. Effects of different concentrations of GFREH on the antioxidant capacity of yak sperm. (A) The ROS staining of yak sperm treatment with various concentrations of GFREH. (B) The relative ROS levels of all treatment groups. (C) The MDA levels in frozen-thawed yak sperm treated with various concentrations of GFREH. (D) The T-AOC level in the yak sperm. (E) The SOD content of the yak sperm. (F) The CAT content in the yak sperm; (G) The GSH-Px content in the yak sperm. Data in (B) are presented as mean ± SEM. Data in (CG) are shown as violin plots representing the distribution of individual ejaculates (n = 18), with the central line indicating the median and dashed lines representing the interquartile range. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 3. Effects of different concentrations of GFREH on the antioxidant capacity of yak sperm. (A) The ROS staining of yak sperm treatment with various concentrations of GFREH. (B) The relative ROS levels of all treatment groups. (C) The MDA levels in frozen-thawed yak sperm treated with various concentrations of GFREH. (D) The T-AOC level in the yak sperm. (E) The SOD content of the yak sperm. (F) The CAT content in the yak sperm; (G) The GSH-Px content in the yak sperm. Data in (B) are presented as mean ± SEM. Data in (CG) are shown as violin plots representing the distribution of individual ejaculates (n = 18), with the central line indicating the median and dashed lines representing the interquartile range. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g003
Figure 4. Effects of different concentrations of GFREH treatment on mitochondrial membrane potential and ATP of yak sperm. (A) Effects of different concentrations of GFREH on MMP in yak sperm. (B) Effects of different concentrations of GFREH treatment on ATP content in yak sperm. Data representing the distribution of individual ejaculates (n = 18), with the central line indicating the median. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 4. Effects of different concentrations of GFREH treatment on mitochondrial membrane potential and ATP of yak sperm. (A) Effects of different concentrations of GFREH on MMP in yak sperm. (B) Effects of different concentrations of GFREH treatment on ATP content in yak sperm. Data representing the distribution of individual ejaculates (n = 18), with the central line indicating the median. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g004
Figure 5. The effect of different concentrations of GFREH treatment on sperm fertilization ability. (A) Fertilization rate statistical chart. (B) Statistical chart of blastocyst rate. Data are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 5. The effect of different concentrations of GFREH treatment on sperm fertilization ability. (A) Fertilization rate statistical chart. (B) Statistical chart of blastocyst rate. Data are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g005
Figure 6. Identification and Analysis of Proteomics. (A) It is a volcano diagram of differential proteins. (B) It is a KEGG enrichment bubble plot of differential proteins. (C) GO function annotation. (D) Mechanism Diagram of the PI3K-AKT signaling pathway. Proteins shown in blue boxes represent downregulated proteins in the KEGG pathway.
Figure 6. Identification and Analysis of Proteomics. (A) It is a volcano diagram of differential proteins. (B) It is a KEGG enrichment bubble plot of differential proteins. (C) GO function annotation. (D) Mechanism Diagram of the PI3K-AKT signaling pathway. Proteins shown in blue boxes represent downregulated proteins in the KEGG pathway.
Antioxidants 15 00156 g006
Figure 7. GFREH reduces FOXO1 expression levels through the PI3K/AKT signaling axis. (A) mRNA expression levels of PIK3R1. (B) mRNA expression levels of AKT1. (C) mRNA expression levels of FOXO1. (D) Quantitative analysis of PIK3R1 protein. (E) Quantitative analysis of AKT1 protein. (F) Quantitative analysis of FOXO1 protein. 0 mg/mL group: No treatment was applied to the sperm cryoprotectant.; 0.75 mg/mL group: GFREH was added at a concentration of 0.75 mg/mL to the sperm cryoprotectant; 0 + AKT activator group: An AKT activator has been incorporated into the sperm cryoprotectant; 0.75 + AKT activator group: Supplement sperm cryoprotectant containing 0.75 mg/mL GFREH with an AKT activator; 0 + PI3K inhibitor group: An PI3K inhibitor has been incorporated into the sperm cryoprotectant; 0.75 + PI3K inhibitor group: Supplement sperm cryoprotectant containing 0.75 mg/mL GFREH with an PI3K inhibitor. Data in (AC) are shown as violin plots, the central line indicating the median and dashed lines representing the interquartile range. Data in (DF) are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Figure 7. GFREH reduces FOXO1 expression levels through the PI3K/AKT signaling axis. (A) mRNA expression levels of PIK3R1. (B) mRNA expression levels of AKT1. (C) mRNA expression levels of FOXO1. (D) Quantitative analysis of PIK3R1 protein. (E) Quantitative analysis of AKT1 protein. (F) Quantitative analysis of FOXO1 protein. 0 mg/mL group: No treatment was applied to the sperm cryoprotectant.; 0.75 mg/mL group: GFREH was added at a concentration of 0.75 mg/mL to the sperm cryoprotectant; 0 + AKT activator group: An AKT activator has been incorporated into the sperm cryoprotectant; 0.75 + AKT activator group: Supplement sperm cryoprotectant containing 0.75 mg/mL GFREH with an AKT activator; 0 + PI3K inhibitor group: An PI3K inhibitor has been incorporated into the sperm cryoprotectant; 0.75 + PI3K inhibitor group: Supplement sperm cryoprotectant containing 0.75 mg/mL GFREH with an PI3K inhibitor. Data in (AC) are shown as violin plots, the central line indicating the median and dashed lines representing the interquartile range. Data in (DF) are presented as mean ± SEM. Different lowercase letters indicate significant differences among groups based on one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05); groups sharing at least one letter are not significantly different.
Antioxidants 15 00156 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, X.; Yu, J.; Li, Y.; Chen, Z.; Zeng, R.; Cen, Y.; Wang, Y.; Zhang, C.; Zhang, D.; Yin, S.; et al. Ginseng Peptide Improves the Cryopreservation Efficiency and Fertilization Potential of Yak Semen via FOXO1/PI3K/AKT Axis. Antioxidants 2026, 15, 156. https://doi.org/10.3390/antiox15020156

AMA Style

Li X, Yu J, Li Y, Chen Z, Zeng R, Cen Y, Wang Y, Zhang C, Zhang D, Yin S, et al. Ginseng Peptide Improves the Cryopreservation Efficiency and Fertilization Potential of Yak Semen via FOXO1/PI3K/AKT Axis. Antioxidants. 2026; 15(2):156. https://doi.org/10.3390/antiox15020156

Chicago/Turabian Style

Li, Xupeng, Jun Yu, Yuan Li, Zhuo Chen, Ruilan Zeng, Ying Cen, Yufan Wang, Chunhai Zhang, Deyi Zhang, Shi Yin, and et al. 2026. "Ginseng Peptide Improves the Cryopreservation Efficiency and Fertilization Potential of Yak Semen via FOXO1/PI3K/AKT Axis" Antioxidants 15, no. 2: 156. https://doi.org/10.3390/antiox15020156

APA Style

Li, X., Yu, J., Li, Y., Chen, Z., Zeng, R., Cen, Y., Wang, Y., Zhang, C., Zhang, D., Yin, S., Xiong, Y., Xiong, X., & Li, J. (2026). Ginseng Peptide Improves the Cryopreservation Efficiency and Fertilization Potential of Yak Semen via FOXO1/PI3K/AKT Axis. Antioxidants, 15(2), 156. https://doi.org/10.3390/antiox15020156

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop